60 Degrees Pharmaceuticals, Inc. (SXTP)
1.08
-0.05
(-4.42%)
USD |
NASDAQ |
Aug 24, 16:00
1.09
+0.01
(+0.93%)
After-Hours: 20:00
60 Degrees Pharmaceuticals Profit Margin (Quarterly) : -1.09K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.09K% |
| March 31, 2026 | -1.29K% |
| December 31, 2025 | -455.3% |
| September 30, 2025 | -438.1% |
| June 30, 2025 | -557.9% |
| March 31, 2025 | -736.3% |
| December 31, 2024 | -754.1% |
| September 30, 2024 | -1.46K% |
| June 30, 2024 | -3.32K% |
| Date | Value |
|---|---|
| March 31, 2024 | |
| December 31, 2023 | -4.67K% |
| September 30, 2023 | |
| June 30, 2023 | -5.34K% |
| March 31, 2023 | -12.08K% |
| September 30, 2022 | -455.6% |
| March 31, 2022 | -552.6% |
| December 31, 2021 | -476.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Harrow, Inc. | -24.44% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 21.86% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -233.6% |
| Return on Assets | -148.3% |
| Return on Invested Capital | -223.7% |
| Gross Profit Margin (Quarterly) | 27.32% |
| Operating Margin (Quarterly) | -1.09K% |
| Return on Net Operating Assets | -482.6% |